Medicinova Inc (MNOV) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Medicinova reported revenue of $409,657. Net income was -$12.0M (a -2928.8% net margin), or -$0.24 per diluted share. Operating margin was -3242.5%. Operating activities generated -$9.8M of cash, leaving -$9.8M of free cash flow. At fiscal year end, Medicinova held $45.6M in total assets against $4.0M in total liabilities, including $30.8M of cash and equivalents.
Open the full interactive Medicinova financials → Quarterly statements, key ratios, valuation history and price charts.
Medicinova Key Stats
| Share Price | $1.50 |
|---|---|
| Market Cap | $73.8M |
| 52-Week Range | $1.18 – $3.45 |
| Shares Outstanding | 49.2 million (basic, 2026 Q2) |
Medicinova Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $4.0M | $0 | $1.0M | $0 | $409,657 |
| Operating Income | -$14.2M | -$10.2M | -$14.6M | -$9.9M | -$12.7M | -$13.3M |
| Pre-Tax Income | -$13.9M | -$10.1M | -$14.1M | -$8.6M | -$11.0M | -$12.0M |
| Income Tax | -$1,648 | $2,568 | $2,822 | $3,047 | $5,537 | $5,994 |
| Net Income | -$13.9M | -$10.1M | -$14.1M | -$8.6M | -$11.0M | -$12.0M |
| Diluted EPS | -$0.31 | -$0.21 | -$0.29 | -$0.17 | -$0.23 | -$0.24 |
Medicinova Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $123,319 | $151,739 | $186,984 | $458,439 |
| Net Income | -$3.1M | -$2.8M | -$2.6M | -$2.3M |
| Diluted EPS | -$0.06 | -$0.06 | -$0.05 | -$0.05 |
Medicinova Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $60.0M | $71.4M | $18.5M | $51.0M | $40.4M | $30.8M |
| Current Assets | $60.7M | $72.0M | $59.0M | $51.2M | $41.1M | $31.0M |
| Total Assets | $75.4M | $87.4M | $74.2M | $66.3M | $55.9M | $45.6M |
| Current Liabilities | $2.2M | $2.8M | $3.2M | $3.3M | $3.0M | $3.8M |
| Total Liabilities | $4.1M | $3.7M | $3.9M | $3.9M | $3.4M | $4.0M |
| Shareholders' Equity | $71.3M | $83.7M | $70.2M | $62.4M | $52.5M | $41.6M |
Medicinova Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$10.8M | -$9.4M | -$12.9M | -$7.4M | -$10.6M | -$9.8M |
| Cash From Investing | -$36,492 | -$28,732 | -$40.0M | $39.9M | -$697 | -$2,899 |
| Cash From Financing | $7.1M | $20.8M | $7,920 | — | — | $244,018 |
| Free Cash Flow | -$10.9M | -$9.4M | -$12.9M | -$7.5M | -$10.6M | -$9.8M |
Figures from Medicinova's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Medicinova financials page for every line item.
Medicinova Company Profile
| Ticker | MNOV |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | La Jolla, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001226616 |
Frequently Asked Questions
What was Medicinova's revenue in fiscal 2025?
Medicinova (MNOV) reported revenue of $409,657 for fiscal 2025.
What is Medicinova's annual revenue history?
Medicinova's annual revenue by fiscal year: 2020: $0; 2021: $4.0M; 2022: $0; 2023: $1.0M; 2024: $0; 2025: $409,657.
What was Medicinova's net income in fiscal 2025?
Medicinova reported net income of -$12.0M for fiscal 2025.
What was Medicinova's earnings per share (EPS) in fiscal 2025?
Medicinova's diluted EPS was -$0.24 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Medicinova generate in fiscal 2025?
Medicinova generated -$9.8M of free cash flow in fiscal 2025.
What was Medicinova's revenue last quarter?
In its most recent reported quarter (2026 Q2), Medicinova reported revenue of $458,439.
How many shares of Medicinova are outstanding?
Medicinova reported a weighted average of 49.2 million basic shares outstanding in 2026 Q2.
What is Medicinova's market cap?
Based on its latest closing price, Medicinova (MNOV) has a market capitalization of about $73.8M.
When does Medicinova's fiscal year end?
Medicinova's fiscal year end, as registered with the SEC, is December 31.
Where is Medicinova headquartered?
Medicinova lists its business address in La Jolla, California in its SEC filings.